2019 Adoptive Cellular Therapy Workshop

• T cells Recognizing Antigen Through Native or Chimeric Receptors
• T cell-intrinsic and -extrinsic Determinants of Response to CAR T cell Therapy
• T cell Reprogramming

SITC 2020

• Concurrent 109: Innate Immunity: The Next Generation of targets for Anti-Cancer Immunotherapy
• Concurrent Session 207: Gene Editing
• Concurrent Session 306: Engineering Immunity: Biomolecular and Genetic Approaches to Generating Novel Therapeutic Function 
• Concurrent Session 307: B Cells

ACCESS ENDURING
MATERIALS HERE

SITC 2019

Primer on Tumor Immunology and Cancer Immunotherapy

• Primer Session 1: Tumor Immunity I
• Primer Session 2: Tumor Immunity II

Annual Meeting

• Concurrent Session 205: Biology of T Cells
• Concurrent Session 207: Harnessing Antigen-Presenting cells to Boost Anti-Tumor Immunity
• Concurrent Session 312: NK Cells: From Basic Science to Clinical Application
• Concurrent Session 314: Tumor and Stromal Cell Biology

VIEW ALL SITC 2019
MATERIALS Here

• Tumor Microenvironment at a Genetic Level

• Link Between Metastatic Genetic Heterogeneity and the Immune Contexture in Colorectal Cancer
• Mutation Drivers of Immunological Responses to Cancer
• Immune Gene Expression as a Discovery Tool for Actionable Immunotherapy Resistance Mechanisms

VIEW ALL 2019 WORKSHOP
MATERIALS

• Germline Analysis of Tumor Immune Signatures in TCGA
• Immune Response in 10,000 Tumor Samples and Correlation with Somatic Alterations
• Enhancing Anti-Tumor Immune Response Using Epigenetic Therapy  
• Translational Systems Immunology in Therapeutics Development
• Immunogenic Cell Death in Cancer Therapy, From Cells to Patients
• Boosting Cancer Immunity: How Oncolytic Viruses Kill Tumor Cells
• The DAMP Hypothesis: Unscheduled Cell Death Regulates the Immune Tumor Microenvironment

Access 2020 Articles

• Original Research: Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
• Original Research: SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA 
• Original Research: SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells

Top Accessed 2019 Articles

• Research Article: α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
• Research Article: Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
• Research Article: Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
• Research Article: Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
• Research Article: Collagen density regulates the activity of tumor-infiltrating T cells

ACCESS THE FULL JOURNAL

Section 1: Basic Principles of Tumor Immunology

• Chapter 2: Introduction to Basic Sciences - Cracking the Code of Cancer Immune Responsiveness and the Evolution of Cancer Biology
• Chapter 3: Human Tumor Antigens Recognized by T Lymphocytes
• Chapter 4: HLA Class I Antigen-Processing Machinery in Cancer
• Chapter 5: Systems Biology of T Cells
• Chapter 6: Activation of CD4+ T Lymphocytes
• Chapter 8: The Role of Breg Cells in Modulating the Antitumor Immune Response
• Chapter 9: The Innate Immune System: Natural Killer Cells
• Chapter 10: The Innate Immune System: Macrophages
• Chapter 11: Natural Killer Cell Effector Mechanisms Against Solid Tumors and Leukemias and Their Exploitation in Immunotherapy
• Chapter 12: Role of Microbiota in Homeostasis, Carcionogenesis and Therapy
• Chapter 13: Chemokines and Chemokine Receptors: Regulators of the Balance Between Antitumor and Protumor Immunity and Promising Targets in Cancer Immunotherapy
• Chapter 14: Role of the Tumor Microenvironment

Section 3: Immune Function in Cancer Patients

• Chapter 25: Introduction to Immune Function in Cancer Patients
• Chapter 26: Tumor-Infiltrating Immune Cells of Myeloid Origin
• Chapter 27: Intratumoral Gene Signatures and Host Genetic Variations Associated with Immune Responsiveness
• Chapter 28: Impact of Somatic Mutations on the local and Systemic Antitumor Immune Response
• Chapter 29: Tumor Antigen Profiling
• Chapter 30: Assessment of Antitumor Immunity in Blood and Lymph Nodes
• Chapter 31: Regulatory T Cell Biology and Its Application in Cancer
• Chapter 32: Systemic Measures of Immune Function in Cancer Patients: Other Suppressive Cellular Mechanisms
• Chapter 33: Circulating Mediators of Tumor-Induced Immune Suppression
• Chapter 34: The Multifaceted Roles of B Cells and Plasma Cells in Antitumor Immunity
• Chapter 35: Systems Immunology Approaches to Cancer Immunotherapy
• Chapter 36: Tumor Microenvironment Metabolism as a Primordial Checkpoint in Antitumor T Cell Immunity
• Chapter 38: Clinical Measures: Imaging, Pseudoprogress and Metabolism